NCT00309855View on ClinicalTrials.gov

Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

PHASE1CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Aging

Interventions

DRUG

Placebo

im and orally

DRUG

Testosterone

injections

DRUG

Anastrazole

orally x 21 days

DRUG

Dutasteride

orally x 21 days

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00309855 - Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men | Biotech Hunter | Biotech Hunter